Neuroscience News and Research RSS Feed - Neuroscience News and Research

Research: MHCI protein moonlights in nervous system to regulate synapses

Research: MHCI protein moonlights in nervous system to regulate synapses

When it comes to the brain, "more is better" seems like an obvious assumption. But in the case of synapses, which are the connections between brain cells, too many or too few can both disrupt brain function. [More]
New electronic EyeCane improves mobility of blind people

New electronic EyeCane improves mobility of blind people

White Canes provide low-tech assistance to the visually impaired, but some blind people object to their use because they are cumbersome, fail to detect elevated obstacles, or require long training periods to master. [More]
Study reveals that people with stress-related inflammation may suffer from depression

Study reveals that people with stress-related inflammation may suffer from depression

Preexisting differences in the sensitivity of a key part of each individual's immune system to stress confer a greater risk of developing stress-related depression or anxiety, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published October 20 in the Proceedings of the National Academy of Sciences. [More]
New study reveals how cancer becomes drug resistant over time

New study reveals how cancer becomes drug resistant over time

Like a colony of bacteria or species of animals, cancer cells within a tumor must evolve to survive. A dose of chemotherapy may kill hundreds of thousands of cancer cells, for example, but a single cell with a unique mutation can survive and quickly generate a new batch of drug-resistant cells, making cancer hard to combat. [More]

Right kind of mental rest helps boost future learning.

A new study, which may have implications for approaches to education, finds that brain mechanisms engaged when people allow their minds to rest and reflect on things they've learned before may boost later learning. [More]
FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's Supplemental New Drug Application (sNDA) for its in-house-discovered AMPA receptor antagonist perampanel for the treatment of primary generalized tonic-clonic (PGTC) seizures. [More]
GlassesOff mobile app improves visual acuity, image processing speed in IAF pilots

GlassesOff mobile app improves visual acuity, image processing speed in IAF pilots

GlassesOff Inc. (OTCBB: GLSO) today announced that statistically significant interim results from a study commissioned by the Israeli Air Force (IAF) demonstrated significant improvements in critical visual functions of IAF pilots through the use of the GlassesOff mobile app. [More]
Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen Research & Development, LLC today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration by its strategic partner Pharmacyclics, Inc. [More]
New drug naming system to be presented at ECNP conference in Berlin

New drug naming system to be presented at ECNP conference in Berlin

What's in a name? Doctors have found that the name of the drug you are prescribed significantly influences how the patient sees the treatment. [More]
Genetic risk for ADHD contributes to language, attention deficits in general population

Genetic risk for ADHD contributes to language, attention deficits in general population

Are deficits in attention limited to those with attention-deficit/hyperactivity disorder (ADHD) or is there a spectrum of attention function in the general population? [More]
Medical school applicants anxious about new MCAT

Medical school applicants anxious about new MCAT

One of the biggest hurdles that college students face if they want to go to medical school is the MCAT - the Medical College Admission Test. The one-day standardized multiple-choice exam, which takes more than five hours to complete, is required for admission to nearly all medical schools in the United States. According to the Association of American Medical Colleges, more than 85,000 students take the MCAT each year. [More]
Otoharmonics receives Class 2 medical device license for Levo system from Health Canada

Otoharmonics receives Class 2 medical device license for Levo system from Health Canada

Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms. [More]
Major scientific breakthrough in understanding retinal degenerative diseases that cause blindness

Major scientific breakthrough in understanding retinal degenerative diseases that cause blindness

An important scientific breakthrough by a team of IRCM researchers led by Michel Cayouette, PhD, is being published today by The Journal of Neuroscience. The Montréal scientists discovered that a protein found in the retina plays an essential role in the function and survival of light-sensing cells that are required for vision. [More]
Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Researchers from the University of Sheffield have found vital new evidence on how to target and reverse the effects caused by one of the most common genetic causes of Parkinson's. [More]
Researchers define the process of Parkinson's disease using genetic mouse model

Researchers define the process of Parkinson's disease using genetic mouse model

Parkinson's Disease is the second most common neurodegenerative disorder. In Germany alone, almost half a million people are affected. The focus of the disease is the progressive degeneration of dopamine-producing nerve cells in a certain region of the midbrain, the substantia nigra. Misfolded proteins are the cause. Until recently, it was unclear why damage is confined to specific nerve cells. [More]
ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

ASU hosts 2014 Collaborative Research in Computational Neuroscience meeting for investigators

Across the country, billions of dollars and millions of hours are spent on studying the inner workings of the brain as scientists search for ways to treat debilitating diseases and injuries such as Alzheimer's, Parkinson's, epilepsy, and traumatic brain injury. Now, with the tremendous growth in basic knowledge driven by these efforts, researchers see a need to integrate their work across the broad scientific disciplines represented in modern neuroscience. [More]
NYSCF names six promising scientists as 2014 NYSCF – Robertson Investigators

NYSCF names six promising scientists as 2014 NYSCF – Robertson Investigators

The New York Stem Cell Foundation today named six of the most promising scientists as its 2014 NYSCF – Robertson Investigators. [More]
MU research finds that neurons actively 'fine tune' for electrical imbalances at genetic level

MU research finds that neurons actively 'fine tune' for electrical imbalances at genetic level

Neurons are electrically charged cells, located in the nervous system, that interpret and transmit information using electrical and chemical signals. Now, researchers at the University of Missouri have determined that individual neurons can react differently to electrical signals at the molecular level and in different ways—even among neurons of the same type. [More]
Carnegie Mellon and Pitt to recognize Mark Roth with 2014 Friend of the CNBC Award

Carnegie Mellon and Pitt to recognize Mark Roth with 2014 Friend of the CNBC Award

Mark Roth, an award-winning senior staff writer at the Pittsburgh Post-Gazette, will receive the 2014 Friend of the Center for the Neural Basis of Cognition Award from Carnegie Mellon University and the University of Pittsburgh. [More]
Research findings point toward new therapeutic target for aggressive breast cancer

Research findings point toward new therapeutic target for aggressive breast cancer

One of the first-known oncogenes has a protein partner that helps breast cancer proliferate and when it's blocked, so is the cancer, scientists report. [More]